Deidre McPhillips

Deidre McPhillips is a journalist at CNN who covers health and medicine. She has a deep interest in public health and how social determinants impact individual health outcomes. Deidre has reported extensively on the connection between housing instability, eviction, and mortality risk, particularly during the COVID-19 pandemic. Her work sheds light on the critical role of stable housing in maintaining overall health and well-being.

58%

The Daily's Verdict

This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.

Bias

85%

Examples:

  • The author tends to focus on the negative impacts of housing instability and eviction on health outcomes.
  • There is a slight emphasis on the role of chronic stress in contributing to excess mortality among renters facing eviction without directly linking it to specific health risks.

Conflicts of Interest

50%

Examples:

  • However, there could be more transparency around any potential conflicts of interest.
  • There is no clear evidence of conflicts of interest or financial ties influencing the author's reporting.

Contradictions

95%

Examples:

  • The author provides consistent and coherent information about housing instability and its impact on health outcomes.
  • There are no major contradictions or discrepancies in the articles provided.

Deceptions

30%

Examples:

  • The author occasionally uses sensational language to grab the reader's attention, such as in the title

Recent Articles

CDC Warns of Rising Covid-19 Levels in US: New KP.2 and KP.3 Variants Account for Over Half of Infections

CDC Warns of Rising Covid-19 Levels in US: New KP.2 and KP.3 Variants Account for Over Half of Infections

Broke On: Friday, 28 June 2024 New Covid-19 variants KP.2 and KP.3, now responsible for over half of new infections in the US, are driving a surge in cases. The CDC advises manufacturers to produce updated vaccines targeting these strains, anticipated by mid-August to late September. With infection rates rising in at least 38 states and hospitalizations and deaths ticking up, health officials urge preventative measures like wearing masks indoors and staying home when sick.
FDA Panel Rejects MDMA-Assisted Therapy for PTSD: Rigorous Clinical Trials and Transparency Needed

FDA Panel Rejects MDMA-Assisted Therapy for PTSD: Rigorous Clinical Trials and Transparency Needed

Broke On: Monday, 03 June 2024 FDA advisory committee votes against MDMA-assisted therapy for PTSD due to concerns over flawed clinical trials and potential misconduct, jeopardizing Lykos Therapeutics' FDA approval and slowing down the expansion of the psychedelics market. Patients with debilitating PTSD symptoms continue their search for effective treatments as experts remain optimistic about psychedelics' potential in mental health disorders.
Revolution in Abortion Care: Telehealth Medication Abortions Surge Amidst State Restrictions

Revolution in Abortion Care: Telehealth Medication Abortions Surge Amidst State Restrictions

Broke On: Tuesday, 14 May 2024 In the wake of the US Supreme Court's Dobbs decision, medication abortions through telehealth have surged, accounting for nearly 20% of all US abortions in late 2023. This increase is attributed to Covid-19 pandemic regulatory flexibilities and growing restrictions on in-person abortion services. However, the rise of telehealth abortions has raised concerns over medical norms and patient safety in states with strict abortion bans.
New Study: Semaglutide in Ozempic Reduces Risk of Serious Kidney Outcomes, Major Cardiovascular Events, and Death for Diabetes Patients with Chronic Kidney Disease

New Study: Semaglutide in Ozempic Reduces Risk of Serious Kidney Outcomes, Major Cardiovascular Events, and Death for Diabetes Patients with Chronic Kidney Disease

Broke On: Friday, 24 May 2024 New findings from the FLOW trial show semaglutide, a compound in Ozempic, reduces risk of serious kidney outcomes, major cardiovascular events and death for diabetes patients with chronic kidney disease.
Preliminary Data Shows Decrease in Drug Overdose Deaths in US for First Time in 5 Years, but Disparities Persist

Preliminary Data Shows Decrease in Drug Overdose Deaths in US for First Time in 5 Years, but Disparities Persist

Broke On: Wednesday, 15 May 2024 Preliminary data from the CDC reveals a decrease in drug overdose deaths in the US for the first time in five years, with about 104,000 fewer fatalities than in 2022. Synthetic opioids like fentanyl remain a significant contributor to overdoses, accounting for around 70% of cases. Harm reduction tools and public health strategies have contributed to the decline, but racial disparities persist.
CDC Warns of Dangers from Fake Botox Injections at Unregulated Med Spas

CDC Warns of Dangers from Fake Botox Injections at Unregulated Med Spas

Broke On: Thursday, 11 April 2024 The CDC is investigating a multistate outbreak of botulism-like illnesses linked to fake Botox injections at unregulated med spas. Medical professionals should be aware and take steps to prevent these counterfeit products from being administered. Patients who have received cosmetic procedures using botulinum toxin products outside a licensed setting should seek immediate medical attention if they experience symptoms similar to botulism.
United States Life Expectancy Increases by 1.1 Years in 2022, Heart Disease and Cancer Remain Leading Causes of Death

United States Life Expectancy Increases by 1.1 Years in 2022, Heart Disease and Cancer Remain Leading Causes of Death

Broke On: Thursday, 21 March 2024 In 2022, the United States saw a slight increase in life expectancy from 76.4 years to 77.5 years at birth, marking an improvement of approximately 1.1 years compared to the previous year's rate of 76.4 years.
Teens Turn to Drugs and Alcohol for Mental Health Coping Mechanisms

Teens Turn to Drugs and Alcohol for Mental Health Coping Mechanisms

Broke On: Friday, 09 February 2024 Teenagers are increasingly turning to drugs and alcohol as a way to cope with mental health issues such as stress, anxiety, depression. The most common reason for using substances is to feel mellow or calm. Nearly three-quarters of respondents cited this reason.

RSV Vaccines for Adults: An Overview

Broke On: Thursday, 07 December 2023 The U.S. Food and Drug Administration (FDA) and the Advisory Committee on Immunization Practices (ACIP) have approved two new vaccines for the prevention of RSV (Arexvy and Abrysvo) for adults aged 60 years and older. 41% of adults aged 60+ with chronic illnesses have received the RSV vaccine. Weekly hospitalizations for respiratory viruses are on the rise.